Hypervision Surgical

100 Lambeth Palace Road, London Institute for Healthcare Engineering, London SE1 7AR, United Kingdom  All United Kingdom companies → Founded 2020
Imaging AI Specialist Medical Device / Hardware Point-of-Care Diagnostics
General Surgery Neurosurgery Plastic Surgery
Surgical AI
Seed — £6.5 million (approximately $8.0M - $8.06M USD)

Products

HyperSnap Surgical System (HSS)
Hypervision Surgical
Surgical AI
HyperSnap Surgical System by Hypervision Surgical is an AI-powered hyperspectral imaging platform that provides real-time, dye-free tissue oxygenation maps and conventional color video to enhance surgical precision and patient safety during open and minimally invasive procedures.

See all 1 product →

About Hypervision Surgical

Hypervision Surgical is a London-based healthcare AI company that has developed an advanced surgical imaging and data analytics platform. Their core technology, the Hyperspectral Intelligence platform, leverages ultra-fast snapshot hyperspectral imaging and real-time artificial intelligence (AI) analytics to provide surgeons with critical tissue-level insights during procedures. This innovative system makes the ‘invisible visible’ by revealing anatomical, physiological, and pathological details beyond the limits of human vision, such as tissue oxygenation, perfusion, and differentiation between healthy and unhealthy tissue, including tumors, nerves, and blood vessels.

For physicians, Hypervision Surgical’s technology offers a non-contact, non-invasive, and dye-free solution that seamlessly integrates into existing surgical workflows, supporting both open and minimally invasive procedures. The system, which has received UKCA certification and FDA clearance for its HYPERSNAP® Surgical System, delivers quantitative tissue oxygenation maps (StO2) alongside conventional color imagery at over 60 frames per second, empowering surgeons with objective, data-driven decision-making to enhance precision, optimize resection, and ultimately improve patient outcomes and safety. Clinical evaluations are underway in UK hospitals, with a primary focus on gastrointestinal and colorectal surgery, as well as neurosurgery.

Focus Areas

AI-powered hyperspectral imaging real-time tissue analytics surgical precision patient safety tissue differentiation perfusion assessment oxygenation mapping minimally invasive surgery colorectal surgery neurosurgery

Business Intelligence

Key InvestorsHERAN Partners, Redalpine, LifeX Ventures, ZEISS Ventures, MedTech Innovator
Partnershipsimec, NVIDIA
TechnologyAI and clinical edge computing, ultra-fast snapshot hyperspectral imaging, Hyperspectral Intelligence platform, on-chip HSI, real-time AI analytics, NVIDIA IGX platform
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

AI-Powered Hyperspectral Imaging
Hypervision Surgical specializes in AI-powered hyperspectral imaging, which goes beyond conventional RGB vision to reveal detailed tissue properties by splitting light into multiple spectral bands. This technology provides objective tissue characterization in real-time.
Real-time Tissue Analytics
Their system delivers quantitative, wide-field information on physiological tissue properties, including perfusion assessment and oxygenation mapping, directly during surgical procedures.
Surgical Precision & Patient Safety
The core goal is to enhance surgical precision and patient safety by equipping clinicians with advanced computer-assisted tissue analysis, aiming to make surgeries more precise, safer, and faster.
Tissue Differentiation
The AI-driven system is capable of wide-field tissue differentiation, identifying critical structures like tumors, normal tissue, nerves, and blood vessels in real-time.
Perfusion Assessment & Oxygenation Mapping
Hypervision Surgical provides quantitative information on tissue and blood vessel perfusion, and delivers real-time quantitative tissue oxygenation maps (StO2), crucial for assessing tissue viability.
Minimally Invasive & Open Surgery
The HyperSnap Surgical System is indicated for use in both open and minimally invasive (e.g., 'keyhole') general surgical applications, integrating with compatible surgical telescopes.
Colorectal Surgery Focus
The technology is under clinical evaluation with a primary focus on gastrointestinal and colorectal surgery, aiming to mitigate complications like anastomotic leakage by providing real-time viability assessment.
Neurosurgery Applications
The system is also being evaluated for neurosurgery, where precise tissue differentiation and maximal tumor resection balanced with healthy tissue preservation are critical for patient outcomes.
Physician Tip

Hypervision Surgical's HYPERSNAPu00ae system offers physicians an objective, data-driven 'extra pair of eyes' in the operating room, extending visual capabilities beyond the limits of human vision. This enables more confident surgical decisions by providing real-time, quantitative insights into tissue properties like oxygenation and perfusion, without the need for exogenous contrast agents or workflow disruption. The seamless integration into existing surgical workflows and the high-frame-rate feedback (60+ fps) ensure instant, critical information for enhanced precision, reduced complications (e.g., anastomotic leakage in colorectal surgery), and improved patient outcomes across various specialties, including neurosurgery.

Hypervision Surgical's technology is designed for seamless integration into existing surgical vision platforms and workflows. Their system, built on the NVIDIA IGX platform and leveraging NVIDIA Clara Holoscan SDK, utilizes GPU-accelerated high-performance computing (NVIDIA CUDA, NVIDIA TensorRT) for real-time AI inference. Furthermore, a strategic partnership with imec focuses on co-developing scalable on-chip hyperspectral sensing technologies for ultra-compact, high-resolution intraoperative imaging systems.

Products by Hypervision Surgical

1 product in the directory

HyperSnap Surgical System (HSS)
Hypervision Surgical
Surgical AI
HyperSnap Surgical System by Hypervision Surgical is an AI-powered hyperspectral imaging platform that provides real-time, dye-free tissue oxygenation maps and conventional color video to enhance surgical precision and patient safety during open and minimally invasive procedures.

Reviews & Opinions

No web reviews on file yet for Hypervision Surgical. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Hypervision Surgical.

Loading videos...

Videos load interactively. If none appear, search YouTube for Hypervision Surgical →

View all on YouTube

Press & Coverage

Hypervision Surgical (Press Release)
Hypervision Surgical Raises u00a317 Million Series A to Power Surgical Intelligence Through Hyperspectral Vision
Hypervision Surgical announced the successful closing of its oversubscribed u00a317 million Series A financing round, led by Heal Capital. This funding will accelerate the commercial deployment of their Hyperspectral Intelligenceu00ae platform and expand clinical adoption.
2026-04
King's College London
King's College London spinout Hypervision Surgical raises u00a317m Series A funding to power surgical intelligence
Hypervision Surgical, a King's College London spinout, secured u00a317 million in Series A funding to advance its UK-certified and FDA-cleared HYPERSNAPu00ae system. The funding will be used to expand clinical use across the UK, Europe, and the US.
2026-04
Photonics Spectra
Hypervision Surgical Raises $23M to Expand Deployment | BioScan - Photonics Spectra
Hypervision Surgical closed a u00a317 million ($23 million) Series A funding round to accelerate commercial deployment and expand clinical adoption of its hyperspectral imaging solution for surgery. The company aims to advance its next-generation sensing technology co-developed with imec.
2026-05
imec
Hypervision Advances Surgical Intelligence with Next-Generation AI-Enabled Spectral Imaging | imec
Hypervision Surgical is accelerating its mission to transform surgical decision-making through a strategic development agreement with imec to co-develop scalable hyperspectral imaging technologies. This partnership aims to deliver ultra-compact, high-resolution intraoperative imaging systems.
2025-07
MedTech Innovator
Hypervision Surgical receives FDA Clearance for HYPERSNAPu00ae Surgical System to improve patient safety
Hypervision Surgical announced that its HYPERSNAPu00ae Surgical System received 510(k) clearance from the U.S. FDA. This marks the first intraoperative platform combining Hyperspectral Imaging (HSI) with AI-powered analytics for real-time surgical decision support.
2025-07
Journal of Physics D: Applied Physics (via PMC)
Hyperspectral abdominal laparoscopy with real-time quantitative tissue oxygenation imaging: a live porcine study - PMC
A study utilized a prototype laparoscopic hyperspectral imaging system from Hypervision Surgical Ltd to provide real-time, high-resolution hyperspectral generated RGB video and simultaneous tissue oxygenation information during a live porcine study. The system integrates a snapshot mosaic camera with a standard laparoscopic setup.
2025-06
Hypervision Surgical (Press Release)
Hypervision Surgical Achieves UKCA Marking for HYPERSNAPu00ae Surgical System
Hypervision Surgical announced that its HYPERSNAPu00ae Surgical System received UK Conformity Assessed (UKCA) marking, confirming compliance with high safety and performance standards for medical devices in the UK. This is the first regulatory clearance for a real-time hyperspectral imaging-based medical device for surgical vision.
2024-12
Hypervision Surgical (Press Release)
Surgical AI venture Hypervision Surgical raises u00a36.5m Seed and adds CMR Surgical founder Martin Frost to the Board
Hypervision Surgical successfully completed an oversubscribed seed funding round, raising u00a36.5 million to accelerate the development of its vision technology and attain regulatory clearance in the US and Europe. Martin Frost CBE, founder of CMR Surgical, joined its board of directors.
2023-06

Frequently Asked Questions

Hypervision Surgical utilizes an AI-powered hyperspectral imaging (HSI) platform, the HYPERSNAPu00ae Surgical System, which integrates on-chip HSI with real-time AI analytics. This technology provides surgeons with objective, data-driven insights into tissue properties like oxygenation and perfusion, extending vision beyond the human eye to improve precision and patient safety by reducing complications.
The HYPERSNAPu00ae Surgical System is cleared for general surgical applications, including both open and minimally invasive procedures. It is particularly beneficial in colorectal surgery for real-time viability assessment to mitigate anastomotic leakage, and is also undergoing clinical evaluation for neurosurgery, enabling precise tissue differentiation and oxygenation mapping.
Hypervision Surgical has achieved FDA 510(k) clearance for its HYPERSNAPu00ae Surgical System, making it the first intraoperative platform to combine HSI with AI-powered analytics for real-time surgical decision support. The company also holds UKCA certification and ISO 13485:2016 certification, demonstrating adherence to international quality and safety standards for medical devices.
Hypervision Surgical is currently evaluating suitable software-based business models, including a fee-per-surgery approach, similar to many other medical devices. The company aims to provide evidence of economic and clinical effectiveness to support reimbursement processes and broaden accessibility to a wider range of healthcare providers.
While specific details on support programs are not extensively detailed, Hypervision Surgical emphasizes expanding collaborations with leading surgeons and surgical centers to ensure successful market launch and smooth integration into clinical practice. They provide contact information for inquiries and support.
Hypervision Surgical has strategic partnerships with imec for co-developing scalable HSI technologies and leverages NVIDIA's IGX platform for real-time AI inference. The company, a King's College London spin-out, secured u00a36.5 million (approximately $8.0M) in seed funding from investors like HERAN Partners, Redalpine, LifeX Ventures, and ZEISS Ventures, and is actively pursuing Series A financing, indicating strong backing and growth potential.

Investors

Who's funded Hypervision Surgical.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.